Detalles de la búsqueda
1.
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood
; 142(10): 865-877, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37300386
2.
HLA peptide-binding pocket diversity modulates immunological complications after cord blood transplant in acute leukaemia.
Br J Haematol
; 204(5): 1920-1934, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38380743
3.
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
Br J Haematol
; 204(1): 250-259, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37784256
4.
Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study.
Haematologica
; 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38186346
5.
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Haematologica
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721749
6.
Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee.
Cytotherapy
; 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483362
7.
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT).
Cytotherapy
; 2024 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416085
8.
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 129(23): 3735-3745, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658621
9.
Comparative analysis of the variability of the human leukocyte antigen peptide-binding pockets in patients with acute leukaemia.
Br J Haematol
; 200(2): 197-209, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263991
10.
Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering.
Cytotherapy
; 25(5): 463-471, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710227
11.
Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond.
Cytotherapy
; 2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38054912
12.
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.
Cytotherapy
; 25(6): 578-589, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941149
13.
Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.
Blood
; 136(5): 623-626, 2020 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32518950
14.
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study.
Haematologica
; 107(5): 1054-1063, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34162176
15.
Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.
Cytotherapy
; 24(3): 249-261, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879990
16.
An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes.
Cytotherapy
; 24(4): 385-392, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35331394
17.
Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment.
Cytotherapy
; 24(9): 884-891, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35705447
18.
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 127(2): 209-218, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33119152
19.
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.
Br J Haematol
; 193(3): 592-601, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838047
20.
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation.
Blood
; 134(11): 892-899, 2019 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31270102